AKT1 and ovarian cancer: In this study, we demonstrated that cisplatin plus nanocurcumin has a synergistic effect by generating antiproliferation and apoptosis in ovarian cancer animal models by downregulation of PI3K/AKT and JAK/STAT3 signaling pathway.